Table 1.
Demographic characteristics of patients with primary immune deficiency (PIDD) and proportion with granulomas, MarketScan and USIDNET Registry
| MarketScan Commercial Data (N=247,474) |
MarketScan Medicaid Data (N=40,395) |
USIDNET Registry (N=4,021) |
||||
|---|---|---|---|---|---|---|
| Selected Variables | # | % | # | % | # | % |
| Agea | ||||||
| 0–19 | 86,783 | 35% | 28,530 | 71% | 2295 | 57% |
| 20–34 | 41,006 | 17% | 3,950 | 10% | 727 | 18% |
| 35–44 | 33,574 | 14% | 2,631 | 7% | 356 | 9% |
| 45–54 | 45,807 | 19% | 2,967 | 7% | 321 | 8% |
| 55–64 | 40,304 | 16% | 2,317 | 6% | 322 | 8% |
| Gender | ||||||
| Male | 88,303 | 36% | 17926 | 44% | 2273 | 57% |
| Female | 159,171 | 64% | 22464 | 56% | 1476 | 37% |
| Unknown | 272 | 7% | ||||
| Race | ||||||
| White | NA | 21,928 | 54% | 1700 | 76% | |
| Black | NA | 8,047 | 20% | 146 | 7% | |
| Hispanic | NA | 2,986 | 7% | 298 | 13% | |
| Other/Unknown | NA | 7,434 | 18% | 101 | 4% | |
| Region | ||||||
| Northeast | 46,354 | 19% | NA | NA | ||
| North Central | 57,463 | 23% | NA | NA | ||
| South | 95,341 | 39% | NA | NA | ||
| West | 43,403 | 18% | NA | NA | ||
| Unknown | 4,846 | 2% | NA | NA | ||
| Metropolitan Statistical Area | ||||||
| No | 32,392 | 13% | NA | NA | ||
| Yes | 215,082 | 87% | NA | NA | ||
| Granuloma | ||||||
| Any granuloma | 2,954 | 1.2% | 624 | 1.5% | 177 | 4.4% |
a
Age based on first PIDD claim during study period for MarketScan data, and age based on age at last visit for USIDNET registry data.